Phathom Pharmaceuticals

IPO

Leading the way to innovative treatments for gastrointestinal diseases

Public · Florham Park, United States · Founded 2018 · $580.3M raised

Employees
201–500
Founded
2018
Business Model
B2B
Total Funding
$580.3M
Last Round
$130.0M Venture RoundJan 2026
Rounds
4
Type
Public

About

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for acid-related gastrointestinal disorders. The company holds exclusive US, European, and Canadian rights to a potassium-competitive acid blocker (PCAB), a next-generation mechanism that offers an alternative to proton pump inhibitors for conditions such as erosive esophagitis and H. pylori infection.

Summary

Phathom Pharmaceuticals is a Biotech company based in Florham Park, United States, founded in 2018. It has raised $580.3M in total across 4 rounds, most recently a $130.0M Venture Round round in Jan 2026. Investors include SVB Capital and New Enterprise Associates.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundPublic OfferingJan 2026
$130.0M

Sign up to see all 5 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Phathom Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/phathom-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/phathom-pharmaceuticals" alt="Phathom Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>